berberine has been researched along with Recrudescence in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, HL; Cao, XC; Chen, HM; Chen, YX; Dou, XT; Fang, JY; Gao, QY; Kang, Q; Li, N; Liu, SD; Liu, ZJ; Ren, JL; Sheng, JQ; Song, YY; Sun, XM; Wang, BM; Xiao, B; Xu, HZ; Yang, XN; Zhu, W; Zou, TH; Zou, XP | 1 |
| Chan, AT; Kwon, S | 1 |
| Bian, ZX; Han, Q; Li, YH; Tang, HZ; Wang, L; Zhao, J; Zou, M | 1 |
| Liu, W; Lv, Z; Peng, G; Su, J; Xu, H | 1 |
| Bian, ZX; Fatima, S; Hu, DD; Lee, NP; Li, YH; Lin, CY; Mu, HX; Xiao, HT | 1 |
| Jiang, XW; Li, FF; Lu, K; Peng, HY; Zhang, H; Zhang, Y; Zhu, YL | 1 |
2 trial(s) available for berberine and Recrudescence
| Article | Year |
|---|---|
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study.
Topics: Adenoma; Adolescent; Adult; Aftercare; Aged; Antineoplastic Agents, Phytogenic; Berberine; Chemoprevention; China; Colonoscopy; Colorectal Neoplasms; Double-Blind Method; Humans; Intention to Treat Analysis; Middle Aged; Placebos; Plants, Medicinal; Recurrence; Safety; Young Adult | 2020 |
Effects of berberine gelatin on recurrent aphthous stomatitis: a randomized, placebo-controlled, double-blind trial in a Chinese cohort.
Topics: Administration, Topical; Adult; Berberine; Chi-Square Distribution; China; Double-Blind Method; Female; Gelatin; Humans; Male; Middle Aged; Pain Measurement; Placebos; Recurrence; Statistics, Nonparametric; Stomatitis, Aphthous; Treatment Outcome | 2013 |
4 other study(ies) available for berberine and Recrudescence
| Article | Year |
|---|---|
Extracting the benefits of berberine for colorectal cancer.
Topics: Adenoma; Antineoplastic Agents, Phytogenic; Aspirin; Berberine; Cardiovascular Diseases; Case-Control Studies; Cell Proliferation; China; Colonic Neoplasms; Colonoscopy; Colorectal Neoplasms; Humans; Placebos; Plants, Medicinal; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence | 2020 |
Anti-inflammatory Efficacy of Combined Natural Alkaloid Berberine and S1PR Modulator Fingolimod at Low Doses in Ulcerative Colitis Preclinical Models.
Topics: Animals; Anti-Inflammatory Agents; Berberine; Cell Line, Tumor; Colitis, Ulcerative; Cytokines; Dextran Sulfate; Drug Therapy, Combination; Fingolimod Hydrochloride; Male; Mice; Molecular Docking Simulation; Molecular Structure; Recurrence; Sphingosine-1-Phosphate Receptors; Spleen; STAT3 Transcription Factor | 2020 |
Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Base Sequence; Berberine; Clostridioides difficile; Colitis; Disease Models, Animal; DNA, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Random Allocation; Recurrence; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Vancomycin; Weight Loss | 2015 |
Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
Topics: Animals; Berberine; Cells, Cultured; Chronic Disease; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Gastrointestinal Agents; Immunosuppressive Agents; Interleukin-17; Interleukin-23; Interleukin-6; Male; Mice, Inbred C57BL; Nuclear Receptor Subfamily 1, Group F, Member 3; Phenotype; Phosphorylation; Recurrence; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; Th17 Cells; Time Factors | 2016 |